Singapore To Make Major Medtech Regulatory Changes Under Economic Growth Plan

Executive Summary: Regulatory and Market Access Improvements for medtech products were on the agenda at last month's Health Products Regulatory Forum in Singapore. These forward-looking changes are seen by the government and the Health Sciences Authority (HSA) as the medtech sector's contribution to initiatives and aims developed by the Singapore Committee on the Future Economy (CFE).

Click here for the full article.

Recent Posts